SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Hubei Minkang Pharmaceutical Ltd. – ‘15-12G’ on 3/31/15

On:  Tuesday, 3/31/15, at 8:53am ET   ·   Effective:  3/31/15   ·   Accession #:  1477932-15-2017   ·   File #:  0-53231

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/31/15  Hubei Minkang Pharmaceutical Ltd. 15-12G      3/31/15    1:9K                                     Discount Edgar/FA

Certification of Termination of Registration of a Class of Securities   —   Form 15
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 15-12G      Certification of Termination of Registration of a   HTML      9K 
                          Class of Securities                                    


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR
SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number  000-53231

 

Hubei Minkang Pharmaceutical Ltd.

(Exact name of registrant as specified in its charter)

 

55 Ubi Ave. 3, #03-01, Mintwell Building, Singapore 408864 

+65-6747-7883 

 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, par value $0.001 per share
(Title of each class of securities covered by this Form)

 

None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

 

Rule 12g-4(a)(1)

x

 
 

Rule 12g-4(a)(2)

¨

 
 

Rule 12h-3(b)(1)(i)

¨

 
 

Rule 12h-3(b)(1)(ii)

¨

 
 

Rule 15d-6

x

 

 

Approximate number of holders of record as of the certification date: 98

 

Pursuant to the requirements of the Securities Exchange Act of 1934 Hubei Minkang Pharmaceutical Ltd. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date:

March 31, 2015

 

By:

/s/ Lee Tong Tai

       

Name:

Lee Tong Tai

       

Title:

Chief Executive Officer

 

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.

 


Dates Referenced Herein

This ‘15-12G’ Filing    Date    Other Filings
Filed on / Effective on:3/31/15None on these Dates
 List all Filings 
Top
Filing Submission 0001477932-15-002017   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 25, 4:08:52.1pm ET